Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ketamine is an injectable anesthesia that has been used in humans and animals since 1970. It is referred to as a "dissociative anesthetic hallucinogen" because it makes people feel detached from their ...

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

CLICK HERE TO GO AD-FREE! Jane C Hu writes at The Microdose: Esketamine is a component of generic ketamine, which is a 50/50 mixture of the enantiomer molecules esketamine and arketamine.

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

Objective: Prior research has shown that ketamine has anti-suicide effects. Additional evidence also suggests that ketamine may offer pro-cognitive effects. Herein, we propose that the anti-suicide ...

The tragic early death of "Friends" star Matthew Perry from a ketamine overdose in 2023 has swung a spotlight on the dangers of unsupervised use of the potent anesthetic. Now, America's leading ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ...